Pharmaceutical manufacturing leader

Kylie Sproston FTSE

Kylie Sproston

Kylie Sproston FTSE

Kylie Sproston is a chartered engineer and internationally experienced leader in the pharmaceutical and biotechnology industries with a strong focus on manufacturing.

She has expertise across the full pharmaceutical product lifecycle and has held senior positions in Australia and the UK in technical and management functions.

She is currently chief executive of Bellberry, a private not-for-profit company that promotes and improves the welfare of research participants and the quality, efficiency and effectiveness of human research projects in Australia.

Kylie also chairs the CRC Advisory Committee which oversees and advises the government on its cooperative research centre program.

_ _ _ _ _

Pharmaceutical manufacturing

ATSE Division

Role and organisation (at time of election)
Chief Executive Officer
Bellberry Limited

Social handles


Kylie Sproston FTSE was elected a Fellow of the Academy in 2021.

See all the ATSE New Fellows 2021 — Download the brochure